Portfolio

Experience includes campaigns for pharmaceuticals, biologics, biosimilars, biotechnology, and medical device brands. Audiences span HCP, Consumer, Payer/Managed Markets, and Community Liaisons. Deliverables include omnichannel campaigns, iCVAs and eDetails, banner and social media ads, websites and landing pages, patient profiles, doctor discussion guides, playbooks, emails, videos, congress materials, experiential events, and sales support and training tools. 

• Allergy: Clarinex
• Antibiotic: Levaquin
• Anticholinergic: Pre-launch brand

• Anticoagulant: Eiquis
• Antiinflammatory: Pre-launch brand
• Asthma: Dupixent
• Atopic Dermatitis: Dupixent
• Bipolar, Major Depressive and Schizophrenia Disorders:

  Abilify, Pristiq, Seroquel XR, Viibryd
• Bladder Cancer: Zusduri

• Breast Cancer: Tykerb
• Breast Implants: Natrelle

• Bronchiectasis: Brinsupri

• Cancer Detection Medical Device: Galleri

• Chronic Pulmonary Obstructive Disease: Tudorza
• Chronic Thromboembolic Pulmonary Hypertension: Adempas
• Community-acquired bacterial pneumonia: Teflaro
• Cosmetic: Juvederm, Surgiderm, Latisse, Natrelle
• Diphtheria and tetanus toxoids and acellular pertussis: Infanrix
• Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated  poliovirus: Kinrix
• Diabetes: Avandia, Onglyza, Kombiglyze
• Epilepsy: Vimpat
• Erectile dysfunction: Levitra
• Eczema: Desonate
• GERD: Aciphex
• Gout: Uloric
• Heart attack and stroke prevention: Plavix
• Hemophilia A: Kogenate
• Hepatitis A: Havrix
• Hepatitis A and B: Ambirix, Twinrix
• Herpes: Valtrex
• High blood pressure: Bystolic
• HIV: Atripla, pharmaceutical franchise with 11 brands
• H. pylori infection: BreathTek UBT
• Human rotavirus: Rotarix
• Hyperkalemia: Lokelma
• Hyponatremia: Samsca
• IBS: Zelnorm
• Infant gas: Mylicon
• Influenza: Fluarix
• Lung cancer: Opdivo
• Metabolic disorders: 2 brands, prelaunch
• Migraine: Imitrex, Treximet

• Multiple myeloma: Darzalex Faspro

• Multiple sclerosis: Extavia, Betaseron, Aubagio, Lemtrada
• Nasal Polyps: Dupixent
• Ocular: Optive, OptivePlus*
• Opioid dependence: Suboxone
• Opioid-induced constipation: Relistor
• Pain relief: Tylenol, Amrix
• Peryonie’s disease: Xiaflex
• Polycystic kidney disease: Pre-launch brand
• Postmenopausal bone density: Prolia
• Psoriasis: Cosentyx,
• Rheumatoid Arthritis: Humira, Kevzara, Rinvoq
• Regenerative tissue: Alloderm
• Rosacea: Finacea
• RSV disease: Synagis*
• Skin adhesive: Dermabond
• Skin cancer: Opdivo

• Systemic lupus erythematosus: Saphnelo
• Transplant anti-rejection: Nulogix
• Weight loss surgery devices: Lapband, Orbera
• Unintended pregnancies: Bayer

• Vaccines: Boostrix, Fluarix, Pediarix, Roarix, Twinrix

* Award-winning campaign